Angola vs Rwanda: Population requiring preventive chemotherapy for schistosomiasis
Angola
5.62 million
in 2024
Rwanda
5.47 million
in 2024
Angola rank
13th
Rwanda rank
14th
Population requiring preventive chemotherapy for schistosomiasis over time
- Angola
- Rwanda
How they compare
Angola currently reports 5.62 million against 5.47 million in Rwanda, a difference of 149,720.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Angola ahead.
Angola ranks 13th and Rwanda ranks 14th of 52 countries.
Angola has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.53 million | 1.64 million | 3.88 million | Angola |
| 2020s | 5.29 million | 4.32 million | 968,660 | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Angola or Rwanda?
- Angola, at 5.62 million against 5.47 million in Rwanda as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Angola and Rwanda?
- 149,720, with Angola ahead.
- How many years of comparable data are there for Angola and Rwanda?
- 15 years are reported by both, from 2010 to 2024.
- How do Angola and Rwanda rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Angola ranks 13th and Rwanda ranks 14th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.